12-10409010-C-A

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_013431.2(KLRC4):​c.188G>T​(p.Gly63Val) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/25 in silico tools predict a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

KLRC4
NM_013431.2 missense, splice_region

Scores

1
18
Splicing: ADA: 0.01771
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.87
Variant links:
Genes affected
KLRC4 (HGNC:6377): (killer cell lectin like receptor C4) Natural killer (NK) cells are lymphocytes that can mediate lysis of certain tumor cells and virus-infected cells without previous activation. They can also regulate specific humoral and cell-mediated immunity. NK cells preferentially express several calcium-dependent (C-type) lectins, which have been implicated in the regulation of NK cell function. This gene is a member of the NKG2 group of genes that are expressed primarily in natural killer (NK) cells. These family members encode transmembrane proteins that are characterized by a type II membrane orientation (have an extracellular C-terminus) and the presence of a C-type lectin domain. This family member is located within the NK complex, a region that contains several C-type lectin genes preferentially expressed in NK cells. Read-through transcription exists between this gene and the downstream KLRK1 (killer cell lectin-like receptor subfamily K, member 1) family member. [provided by RefSeq, Dec 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.14363948).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
KLRC4NM_013431.2 linkuse as main transcriptc.188G>T p.Gly63Val missense_variant, splice_region_variant 2/4 ENST00000309384.3 NP_038459.1
KLRC4-KLRK1NM_001199805.1 linkuse as main transcriptc.-487G>T splice_region_variant, 5_prime_UTR_variant 2/13 NP_001186734.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
KLRC4ENST00000309384.3 linkuse as main transcriptc.188G>T p.Gly63Val missense_variant, splice_region_variant 2/41 NM_013431.2 ENSP00000310216 P1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 16, 2022The c.188G>T (p.G63V) alteration is located in exon 2 (coding exon 2) of the KLRC4 gene. This alteration results from a G to T substitution at nucleotide position 188, causing the glycine (G) at amino acid position 63 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
5.2
DANN
Benign
0.86
DEOGEN2
Benign
0.069
T
Eigen
Benign
-0.70
Eigen_PC
Benign
-0.98
FATHMM_MKL
Benign
0.019
N
LIST_S2
Benign
0.42
T
M_CAP
Benign
0.0012
T
MetaRNN
Benign
0.14
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.92
L
MutationTaster
Benign
1.0
N
PrimateAI
Benign
0.22
T
PROVEAN
Uncertain
-3.6
D
REVEL
Benign
0.051
Sift
Benign
0.13
T
Sift4G
Benign
0.067
T
Polyphen
1.0
D
Vest4
0.068
MutPred
0.49
Gain of catalytic residue at P66 (P = 8e-04);
MVP
0.44
MPC
0.38
ClinPred
0.33
T
GERP RS
-2.1
Varity_R
0.079
gMVP
0.14

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.018
dbscSNV1_RF
Benign
0.22
SpliceAI score (max)
0.50
Details are displayed if max score is > 0.2
DS_AL_spliceai
0.50
Position offset: 0

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr12-10561609; API